ECHA management board elects new deputy chairman
Martin Lynch takes the role
Lynch, from Ireland, will hold the role for the next two years. Dr Thomas Jakl, from Austria, is chairman.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Ingredients
Brenntag launches BYPHAR biopharma raw material portfolio spanning R&D through commercial GMP manufacture
The three-tier range — covering non-GMP research materials through LBLE critical-grade excipients — consolidates regulatory documentation, global supply reliability and technical support for mAbs, CGT, ADCs and nucleic acid production under one brand
Ingredients
GELITA launches ultra-low endotoxin MEDELLAPRO grade targeting sensitive biomedical applications
The new gelatin excipient, featuring less than ten endotoxin units per gram, expands GELITA's ECE portfolio for drug delivery, vaccine stabilisation and 3D bioprinting, alongside recombinant animal-free collagen development